KR101456415B1 - The method of manufacturing bar-shaped functional food for diet - Google Patents
The method of manufacturing bar-shaped functional food for diet Download PDFInfo
- Publication number
- KR101456415B1 KR101456415B1 KR1020140045175A KR20140045175A KR101456415B1 KR 101456415 B1 KR101456415 B1 KR 101456415B1 KR 1020140045175 A KR1020140045175 A KR 1020140045175A KR 20140045175 A KR20140045175 A KR 20140045175A KR 101456415 B1 KR101456415 B1 KR 101456415B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- weight
- functional food
- mixed liquid
- bar
- Prior art date
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 28
- 235000005911 diet Nutrition 0.000 title claims description 19
- 230000037213 diet Effects 0.000 title claims description 15
- 238000004519 manufacturing process Methods 0.000 title abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 57
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 26
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000011869 dried fruits Nutrition 0.000 claims abstract description 14
- 239000007788 liquid Substances 0.000 claims abstract description 14
- 239000007787 solid Substances 0.000 claims abstract description 14
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 13
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 13
- 239000011718 vitamin C Substances 0.000 claims abstract description 13
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 10
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 10
- 239000001259 polydextrose Substances 0.000 claims abstract description 10
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 10
- 229940035035 polydextrose Drugs 0.000 claims abstract description 10
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 8
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 8
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 8
- 235000021014 blueberries Nutrition 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 8
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 7
- 229940094952 green tea extract Drugs 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000005520 cutting process Methods 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 235000014571 nuts Nutrition 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 12
- 229960004203 carnitine Drugs 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 6
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 5
- 235000004634 cranberry Nutrition 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 240000007651 Rubus glaucus Species 0.000 claims description 4
- 244000000231 Sesamum indicum Species 0.000 claims description 4
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 4
- 235000020733 paullinia cupana extract Nutrition 0.000 claims description 4
- 244000144725 Amygdalus communis Species 0.000 claims description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 3
- 241000408747 Lepomis gibbosus Species 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 3
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 3
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 3
- 240000006365 Vitis vinifera Species 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- 235000020224 almond Nutrition 0.000 claims description 3
- 239000004203 carnauba wax Substances 0.000 claims description 3
- 235000013869 carnauba wax Nutrition 0.000 claims description 3
- 235000020226 cashew nut Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 235000020236 pumpkin seed Nutrition 0.000 claims description 3
- 235000020238 sunflower seed Nutrition 0.000 claims description 3
- 235000020234 walnut Nutrition 0.000 claims description 3
- 241000758791 Juglandaceae Species 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims 1
- 241000208223 Anacardiaceae Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 235000001916 dieting Nutrition 0.000 abstract description 14
- 230000037228 dieting effect Effects 0.000 abstract description 14
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract description 12
- 238000002156 mixing Methods 0.000 abstract description 8
- 230000001055 chewing effect Effects 0.000 abstract description 6
- 239000005556 hormone Substances 0.000 abstract description 4
- 229940088597 hormone Drugs 0.000 abstract description 4
- 230000028327 secretion Effects 0.000 abstract description 4
- 235000004347 Perilla Nutrition 0.000 abstract description 3
- 244000124853 Perilla frutescens Species 0.000 abstract description 3
- 235000019627 satiety Nutrition 0.000 abstract description 3
- 230000036186 satiety Effects 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 230000035764 nutrition Effects 0.000 abstract description 2
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 229940018492 plantago seed Drugs 0.000 abstract 1
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 210000000577 adipose tissue Anatomy 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 10
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 9
- 208000008589 Obesity Diseases 0.000 description 8
- 235000020824 obesity Nutrition 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 235000013325 dietary fiber Nutrition 0.000 description 7
- 230000004580 weight loss Effects 0.000 description 7
- 101800000224 Glucagon-like peptide 1 Proteins 0.000 description 6
- 102100040918 Pro-glucagon Human genes 0.000 description 6
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N Hydroxycitric acid Chemical compound OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 230000035882 stress Effects 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 235000000885 Garcinia xanthochymus Nutrition 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 230000000378 dietary effect Effects 0.000 description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 4
- 229940090949 docosahexaenoic acid Drugs 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000167854 Bourreria succulenta Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000593508 Garcinia Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 235000019693 cherries Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 3
- 229940089491 hydroxycitric acid Drugs 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- 229940012843 omega-3 fatty acid Drugs 0.000 description 3
- 239000006014 omega-3 oil Substances 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102000004146 ATP citrate synthases Human genes 0.000 description 2
- 108090000662 ATP citrate synthases Proteins 0.000 description 2
- 244000226021 Anacardium occidentale Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 102000002666 Carnitine O-palmitoyltransferase Human genes 0.000 description 2
- 108010018424 Carnitine O-palmitoyltransferase Proteins 0.000 description 2
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 2
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 101000783356 Naja sputatrix Cytotoxin Proteins 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000002340 cardiotoxin Substances 0.000 description 2
- 231100000677 cardiotoxin Toxicity 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000019525 fullness Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000003871 intestinal function Effects 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- -1 polyphenol compound Chemical class 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000004260 weight control Methods 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 101100337060 Caenorhabditis elegans glp-1 gene Proteins 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000546193 Clusiaceae Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 206010014733 Endometrial cancer Diseases 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 244000119461 Garcinia xanthochymus Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010050661 Platelet aggregation inhibition Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-O S-adenosyl-L-methionine Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H]([NH3+])C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-O 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000020650 eye health related herbal supplements Nutrition 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000003880 negative regulation of appetite Effects 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000000079 pharmacotherapeutic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0612—Carnitine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2118—Garcinia cambogia, hydroxycitric acid
Abstract
Description
본 발명은 바(Bar) 형상의 다이어트용 기능성 식품 제조방법에 관한 것으로, 보다 상세하게는 액상의 프락토올리고당 20.0~25.0중량%와 블루베리 농축액 2.5~3.5중량%를 포함하는 혼합액을 100℃의 온도로 가열하면서 교반하는 단계; 80℃의 온도에서 상기 혼합액에 차전자피 분말 1.0~3.0중량%, L-카르니틴 분말 2.0~2.5중량%, 폴리덱스트로스 분말 1.6~2.4중량%, 녹차추추물 분말 0.2~0.4중량% 및 가르시니아 캄보지아 분말 1.5~2.5중량%를 투입하여 혼합하는 단계; 40~45℃의 온도에서 상기 분말 혼합액에 고형의 견과류 20.0~25.0중량%, 건조과일 7.0~11.0중량% 및 볶음들깨 4.0~5.0중량%를 투입하여 혼합하는 단계; 상기 분말 및 고형물의 혼합액을 바 형상으로 압축 성형 및 절단하는 단계; 및 40~ 45℃의 열풍으로 1~3분간 건조시킨 후 상온에서 냉각하는 단계로 이루어진 것을 특징으로 한다.More particularly, the present invention relates to a method for producing a functional food for a diet in the form of a bar. More particularly, the present invention relates to a method for producing a functional food for dieting, comprising the steps of: Stirring with heating to a temperature; Carnitine powder, 2.0 to 2.5% by weight of polydextrose powder, 1.6 to 2.4% by weight of polydextrose powder, 0.2 to 0.4% by weight of green tea extract powder and 1.5 to 2.5% by weight of carnauba wax powder, % By weight; Adding 20.0 ~ 25.0% by weight of solid nuts, 7.0 ~ 11.0% by weight of dried fruits and 4.0 ~ 5.0% by weight of roasted sesame seeds to the powder mixture at a temperature of 40 to 45 ° C; Compressing and cutting a mixture of the powder and the solid into a bar shape; And drying in hot air at 40 to 45 DEG C for 1 to 3 minutes, followed by cooling at room temperature.
또한, 바(Bar) 형상으로 제조하여 다이어트에 효과가 있는 기능성 성분을 용이하게 많은 양을 추가할 수 있고, 씹힘 효과에 의해 GLP-1(글루카곤 유사 펩타이드-1) 호르몬의 분비를 촉진하여 뇌가 포만감을 느껴 체중 감소에 도움을 줄 수 있도록 하며, 비타민C를 도포하여 영양소를 보충할 수 있도록 한 점에 특징이 있다.
In addition, it is possible to easily add a large amount of a functional ingredient which is effective for dieting by being manufactured in the form of a bar, and promoting the secretion of GLP-1 (glucagon-like peptide-1) hormone by the chewing effect, It helps to lose weight and helps to lose weight. It is also characterized by its ability to supplement nutrients by applying vitamin C.
경제성장에 따른 식생활 변화로 인하여 육류 등 고지방 식품의 섭취가 늘어 이에 따른 비만 내지 과체중 인구가 늘고 있으며, 그로 인한 각종 성인병의 발병률 증가로 이어지고 있다.Due to changes in dietary habits due to economic growth, the consumption of high-fat foods such as meat increases, resulting in an increase in the obesity and overweight population, leading to an increase in the incidence of various adult diseases.
1996년 세계보건기구(WHO)는 비만을 고혈압, 당뇨병 등과 같은 질병 유발률과 이로 인한 사망률을 증가시키는 질병으로 규정한 바 있고, 2012년 한국의 사회지표에 따르면 2011년도에 여성 비만유병률(체질량지수 25㎏/㎡ 이상)은 28.6%로서 역대 최고치를 기록하였고, 남성의 비만유병률도 35.2%로서 높은 수준을 유지하고 있다.In 1996, the World Health Organization (WHO) defined obesity as a disease that increases the incidence of diseases such as hypertension, diabetes, and mortality, and according to Korean social indicators in 2012, the prevalence of female obesity (body mass index ㎏ / ㎡) was 28.6% and the prevalence rate of obesity in men was 35.2%.
비만은 고혈압, 당뇨병, 동맥경화, 지방간 등 질병을 유발 또는 악화시키는 것이 임상학적으로 밝혀졌고, 특히 여성의 경우 비만인 경우에 자궁내막암 발병률이 정상인들 보다 현저히 높은 것으로 보고되고 있다.Obesity has been clinically proven to cause or exacerbate diseases such as hypertension, diabetes, atherosclerosis, fatty liver, and especially in women, the incidence of endometrial cancer is significantly higher than in normal people.
비만의 원인에 대하여는 명확히 밝혀지지는 않았으나, 운동부족과 더불어 식생활 방식이 주요 원인인 점에 대하여는 의견이 일치한다. The cause of obesity has not been clearly elucidated, but it is in agreement with the lack of exercise and the fact that eating habits are the main cause.
따라서 비만을 치료하기 위해서는 운동과 더불어 식이요법이 중요하므로, 본 발명은 다이어트를 함에 있어 체지방의 효과적인 분해를 통한 체중 감소를 극대화하고, 반면에 근육량의 감소는 최소화하기 위한 기능성 식품의 제조방법을 제시한다.
Therefore, dietary therapy is important in order to treat obesity. Therefore, the present invention proposes a method of manufacturing a functional food for maximizing weight loss through effective decomposition of body fat in dieting, while minimizing reduction of muscle mass do.
기존에 체중 조절 내지 감량을 위한 기능성 식품에 관한 특허로는 등록특허 제10-1219779호와 등록특허 제10-1123208호 등이 있다.[0004] Patent patents relating to functional foods for weight control and weight loss have been disclosed in Patent Documents 10-1219779 and 10-1123208.
그러나 등록특허 제10-1219779호에는 다이어트용 양갱 및 그 조성물에 관한 내용이 개시되어 있으나, 열량과 당량의 함량이 높은 물엿을 주원료로 사용함으로써 체지방 감소효과가 불확실하고 제조과정에서 비타민C 등 열에 약한 영양소가 상당부분 파괴되는 문제점이 있다.However, Patent Document 10-1219779 discloses contents of diet melon and its composition. However, by using starch syrup having high content of calorie and equivalents as its main ingredient, the effect of reducing body fat is uncertain, There is a problem that the nutrients are largely destroyed.
또한, 등록특허 제10-1123208호에는 국수, 케이크, 푸딩 등으로 제조한 체중조절용 식품에 대한 내용이 개시되어 있으나, 간편하게 섭취할 수 있는 것과는 거리가 있다.In addition, although Patent Document 10-1123208 discloses a food for weight control made of noodles, cakes, puddings and the like, it is far from what can be easily ingested.
또한, 기존에 알약 내지 드링크제 형태의 다이어트용 기능성 식품에 관한 기술이 다수 존재하나, 체중 감소에 유용한 기능성 성분 또는 재료를 용이하게 많은 양을 첨가할 수 없는 한계가 있다.In addition, although there exist many technologies related to functional foods for diets in the form of pills or drinks, there is a limit in that a large amount of functional ingredients or materials useful for weight reduction can not be easily added.
즉, 기존의 다이어트용 기능성 식품은 체중 감량의 효과가 불확실한 성분을 주원료로 하여 제조단가를 낮출 수 있으나 체지방 감소 효과가 높지 않고, 열에 의한 영양소 파괴로 다이어트 시 부족하기 쉬운 영양분 특히 비타민C가 결핍될 우려가 있으며, 간편하게 섭취하거나 섭취시 미감을 증대시킬 수 있는 것과는 거리가 있고, 기능성 성분 내지 재료를 용이하게 많은 양을 첨가할 수 없는 문제점이 있다.
In other words, the conventional functional food for diet can lower the production cost by using the ingredient whose uncertain effect of weight loss is unclear, but it is not effective to decrease body fat, and the nutrient destruction due to heat, There is a concern that it is far from being able to easily ingest or increase aesthetic sensation upon ingestion, and there is a problem that a large amount of a functional ingredient or a material can not be easily added.
상기와 같은 문제점을 해결하기 위해 본 발명은 바(Bar) 형상으로 제조하여 다이어트에 효과가 있는 기능성 성분을 용이하게 많은 양을 추가할 수 있도록 함에 그 목적이 있다.DISCLOSURE OF THE INVENTION In order to solve the above problems, it is an object of the present invention to make it possible to easily add a large amount of a functional ingredient, which is effective for dieting, in a bar shape.
또한, L-카르니틴, 가르시니아 캄보지아 추출물 및 녹차추출물 등을 이용하여 체지방 감소 및 분해의 효과가 있도록 하고, 오메가-3 지방산, 식이섬유, 견과류, 건조과일을 함유하도록 하여 쉽게 포만감을 느끼게 하고자 함과 동시에 특히 견과류와 건조과일을 포함시켜 씹는 맛의 개선과 다이어트로 인한 스트레스 해소의 효과가 있도록 하며, 차전자피, 프락토올리고당을 사용하여 장기능 활성화와 배변활동을 돕고자 하는데 그 목적이 있다.In addition, it is intended to make the effect of reducing and decomposing body fat, using omega-3 fatty acids, dietary fibers, nuts and dried fruits, so that it is possible to easily feel fullness by using L-carnitine, Garcinia cambogia extract and green tea extract Especially, it contains nuts and dried fruits to improve the taste of chewing and to relieve the stress caused by dieting. It is also intended to help stimulate bowel function and bowel activity by using cardiotoxin and fructooligosaccharide.
또한, 제조 과정에서 기능성 성분의 손실을 최소화하고자 하는 데 그 목적이 있다.It is also an object of the present invention to minimize the loss of functional components during the manufacturing process.
또한, 비타민C 분말을 식품의 표면에 도포하여 영양보충과 함께 섭취 후 식욕을 억제하고자 하는 데 그 목적이 있다.
It is also intended to apply vitamin C powder to the surface of food to suppress appetite after ingestion with nutritional supplement.
상기와 같은 목적을 달성하기 위해 본 발명에 따른 다이어트용 기능성 식품 제조방법은, 액상의 프락토올리고당 20.0~25.0중량%와 블루베리 농축액 2.5~3.5중량%를 포함하는 혼합액을 100℃의 온도로 가열하면서 교반하는 단계; 80℃의 온도에서 상기 혼합액에 차전자피 분말 1.0~3.0중량%, L-카르니틴 분말 2.0~2.5중량%, 폴리덱스트로스 분말 1.6~2.4중량%, 녹차추추물 분말 0.2~0.4중량% 및 가르시니아 캄보지아 분말 1.5~2.5중량%를 투입하여 혼합하는 단계; 40~45℃의 온도에서 상기 분말 혼합액에 고형의 견과류 20.0~25.0중량%, 건조과일 7.0~11.0중량% 및 볶음들깨 4.0~5.0중량%를 투입하여 혼합하는 단계; 상기 분말 및 고형물의 혼합액을 바(Bar) 형상으로 압축 성형 및 절단하는 단계; 40~45℃의 열풍으로 1~3분간 건조시킨 후 상온에서 냉각하는 단계로 이루어진 것을 특징으로 한다.
In order to accomplish the above object, the present invention provides a method for producing a functional food for diets, comprising heating a mixed liquid containing 20.0 to 25.0% by weight of fructooligosaccharide in a liquid phase and 2.5 to 3.5% by weight of a concentrated liquid of blueberry, ; Carnitine powder, 2.0 to 2.5% by weight of polydextrose powder, 1.6 to 2.4% by weight of polydextrose powder, 0.2 to 0.4% by weight of green tea extract powder and 1.5 to 2.5% by weight of carnauba wax powder, % By weight; Adding 20.0 ~ 25.0% by weight of solid nuts, 7.0 ~ 11.0% by weight of dried fruits and 4.0 ~ 5.0% by weight of roasted sesame seeds to the powder mixture at a temperature of 40 to 45 ° C; Compressing and cutting the mixture of the powder and the solid into a bar shape; Followed by drying for 1 to 3 minutes with hot air at 40 to 45 캜, followed by cooling at room temperature.
또한, 비타민C 분말 80~150mg을 액상의 프락토올리고당 또는 벌꿀과 부피 대비 1:1의 비율로 혼합하여 그 혼합물을 상기 냉각된 바(Bar) 형상의 다이어트용 기능성 식품의 표면에 도포하는 것을 특징으로 한다.
Also, it is characterized in that 80 to 150 mg of vitamin C powder is mixed with liquid fructooligosaccharide or honey in a ratio of 1: 1 by volume, and the mixture is applied to the surface of the cooled functional food for dieting in the form of a bar .
또한, 상기 견과류는 해바라기씨, 호박씨, 아몬드, 캐슈넛, 호두, 잣 또는 은행 중에서 어느 하나 이상이 선택되어 지고, 상기 건조과일은 크랜베리, 블루베리, 포도, 라즈베리 또는 체리 중에서 어느 하나 이상이 선택되어 지는 것을 특징으로 한다.
At least one of sunflower seeds, pumpkin seeds, almonds, cashew nuts, walnuts, pine nuts, or banknotes is selected as the nuts, and the dried fruits are selected from at least one of cranberry, blueberry, grape, raspberry or cherry .
또한, 상기 분말 성분을 혼합하는 단계에 마테추출물 분말 0.5~0.7중량% 및 과라나추출물 분말 0.5~0.7중량%를 더 첨가하는 것을 특징으로 한다.
Also, in the step of mixing the powder components, 0.5 to 0.7% by weight of a matte extract powder and 0.5 to 0.7% by weight of a guarana extract powder are further added.
본 발명에 따른 바(Bar) 형상의 다이어트용 기능성 식품 제조방법은 바(Bar) 형상으로 제조하여 다이어트에 효과가 있는 기능성 성분을 용이하게 많은 양을 추가할 수 있을 뿐만 아니라 씹힘 효과에 의한 GLP-1(글루카곤 유사 펩타이드-1) 호르몬의 분비를 촉진하여 뇌가 포만감을 느끼도록 하는 효과가 있다.The bar-shaped functional food manufacturing method for diets according to the present invention can be manufactured in a bar shape so that a functional ingredient effective for dieting can be easily added in large quantities, and a GLP- 1 (glucagon-like peptide-1) hormone secreted by the brain.
또한, L-카르니틴, 가르시니아 캄보지아 추출물 및 녹차추출물 등을 이용하여 체지방 감소 및 분해의 효과가 있고, 오메가-3 지방산, 식이섬유, 견과류, 건조과일을 함유하도록 하여 쉽게 포만감을 느끼게 하고자 함과 동시에 특히 견과류와 건조과일을 포함시켜 씹는 맛의 개선과 다이어트로 인한 스트레스 해소의 효과가 있으며, 차전자피, 프락토올리고당을 사용하여 장기능 활성화와 배변활동을 원활하게 하는 효과가 있다.In addition, there is an effect of reducing and decomposing body fat by using L-carnitine, Garcinia cambogia extract, green tea extract, etc., and oily-3 fatty acid, dietary fiber, nuts and dry fruit are contained, It contains nut and dried fruit to improve the taste of chewing and to relieve the stress caused by diet. It also has the effect of facilitating bowel function and bowel activity by using cardiotoxin and fructooligosaccharide.
또한, 제조 과정에서 기능성 성분의 손실을 최소화하는 효과가 있다.In addition, there is an effect of minimizing the loss of functional components in the manufacturing process.
또한, 비타민C 분말을 상기 기능성 식품의 표면에 도포하여 영양보충과 함께 섭취 후 식욕을 억제시키는 효과가 있다.
Also, there is an effect that vitamin C powder is applied to the surface of the above-mentioned functional foods to supplement the nutritional supplement and suppress appetite after ingestion.
본 발명에 사용되는 주요 제조성분에 관하여 설명한다.
The main components used in the present invention are described below.
비타민B 복합체의 하나인 카르니틴은 지방산이 분해되어 에너지로 변환되는 과정에서 지방산이 미토콘드리아로 전달되는데 작용하는 효소이고, 카르니틴의 두 가지 이성질체 중 하나인 L-카르니틴은 세포 내 에너지 생성을 위해 미토콘드리아 내 ß-oxidation 을 증가시킬 뿐만 아니라 지방산 산화를 조절하는 CPT(Carnitine Palmitoyl Transferase)-1 효소의 기질로 사용된다. L-카르니틴이 결핍될 경우 지방산이 세포질 내에 축적되어 과산화를 초래할 염려가 있고, L-카르니틴을 보충하여 섭취할 경우 체지방의 분해가 촉진되는데, 이는 장쇄지방산이 카르니틴과 결합하여 아실카르니틴으로 변하면서 미토콘드리아 내막을 통과하는 것이 가능해지기 때문이다.
Carnitine, one of the vitamin B complexes, is an enzyme that acts on the transfer of fatty acids to mitochondria in the process of decomposition of fatty acids into energy. L-carnitine, one of the two isomers of carnitine, -oxidation as well as a substrate for the CPT (Carnitine Palmitoyl Transferase) -1 enzyme that regulates fatty acid oxidation. When L-carnitine is deficient, fatty acids accumulate in the cytoplasm and may cause peroxidation. When supplemented with L-carnitine, the body fat decomposition is accelerated because long chain fatty acids bind to carnitine to convert to acyl carnitine, It is possible to pass through the inner membrane.
가르시니아 캄보지아(Garcinia Cambogia)는 인도를 비롯한 남부아시아에서 자생하는 Guttiferae과의 열대성 과일나무로서 그 추출물은 가르시니아 캄보지아의 열매 특히 과피를 추출하여 분말화한 것이다. 열수로 추출된 가르시니아 캄보지아 추출물의 주된 성분은 HCA(Hydroxy Citric Acid)이며, 체내에서 탄수화물을 지방으로 전환시키는 효소(ATP-citrate lyase)의 활성을 억제하여 체지방을 감소시키는 역할을 한다. 또한 HCA는 ATP 구연산리아제와의 결합력이 강하므로 당질이 지방으로 변환되는 것을 차단시키는 기능을 한다.
Garcinia Cambogia is a tropical fruit tree with Guttiferae native to southern Asia, including India, whose extract is extracted and powdered, especially the fruit of Garcinia cambogia. The main ingredient of the extracts of garcinia cambogia extracted with hot water is HCA (Hydroxy Citric Acid), which acts to reduce the body fat by inhibiting the activity of the enzyme (ATP-citrate lyase) which converts carbohydrates into fat in the body. In addition, HCA has a strong binding force with ATP citrate lyase and thus functions to block the conversion of saccharides into fat.
녹차의 성분 중 카테킨은 폴리페놀 화합물의 일종으로서, 카테킨은 크게 8가지로 분류되는데 이 중 EC, EGC, ECG, EGCG가 카테킨류로 불리워지며, 이 중에서 EGCG가 가장 생리활성이 높은 것으로 알려져 있다. 또한 녹차의 성분 중 폴리페뇰은 니코틴과 결합하여 체외로 배출하도록 도와주는 역할을 하고, 녹차의 칼륨 성분은 고혈압 방지에 효과가 있는 것으로 알려져 있다.
Catechin is a kind of polyphenol compound. ECK, EGC, ECG and EGCG are called catechins. Among them, EGCG is the most physiologically active. Also, among the components of green tea, polyphenol is combined with nicotine to help release it out of the body, and potassium component of green tea is known to be effective in preventing hypertension.
오메가-3 지방산은 주로 생선, 해양 포유동물, 들깨 등에서 나오는데, 필수지방산인 알파-리놀렌산과 DHA, 도코사펜타엔산(DPA) 및 EPA를 함유한다. 여기서 알파-리놀렌산은 아마씨 또는 호두 기름에 많이 들어 있는데, 최근 연구결과에 따르면 알파-리놀렌산을 섭취하면 혈중 콜레스테롤이 저하되고 심혈관 질환의 발생을 감소시킨다. DHA(Docosa Hexaenoic Acid)는 고도 불포화지방산의 일종으로 인체 내에서 자연적으로 합성이 이루어지지 않기 때문에 DHA성분을 포함한 음식을 섭취해야만 하고, DHA는 혈중 콜레스테롤을 낮추는 기능을 한다. EPA(Eicosapentaenoic Acid)는 혈중 콜레스테롤을 저하시킴과 아울러 뇌기능을 촉진시키는 작용을 한다.Omega-3 fatty acids are mainly found in fish, marine mammals, and perilla, which contain essential fatty acids, alpha-linolenic acid and DHA, docosa-pentaenoic acid (DPA) and EPA. Alpha-linolenic acid is present in many flaxseed or walnut oil. Recent studies have shown that alpha-linolenic acid reduces blood cholesterol and reduces the incidence of cardiovascular disease. DHA (Docosa Hexaenoic Acid) is a type of polyunsaturated fatty acid that does not naturally synthesize in the human body, so it must eat foods containing DHA, and DHA functions to lower blood cholesterol. EPA (Eicosapentaenoic Acid) lowers blood cholesterol and promotes brain function.
특히 들깨기름에서 오메가-3 지방산(60% 이상)이 많이 나오는데, 이는 아마씨기름에서 나오는 양(45%)보다 많은 양이다.
Omega-3 fatty acids (more than 60%) are particularly common in perilla oil, which is more than the amount of flaxseed oil (45%).
식이섬유는 체내 소화기관에서 소화, 흡수되지 않고 거의 그대로 배설되는 난소화성 고분자물질로 포만감을 증대시키고, 콜레스테롤을 조절하며, 배변활동을 보조하고, 식후 혈당의 상승을 억제하는 기능을 한다. 이러한 식이섬유에는 구아검, 글루코만난, 귀리, 난소화성 말토덱스트린, 대두, 보리, 옥수수겨, 이눌린, 차전자피, 폴리덱스트로스 등이 있다. 특히 말토덱스트린은 혈당억제 및 콜레스테롤 수치를 저하시키는 효과가 크고, 산성 및 열에 대한 안정성이 커서 식품으로 제조하기가 용이한 장점이 있다.
Dietary fiber is an indigestible polymer substance that is excreted almost exclusively in digestive organs of the body. It functions to increase satiety, control cholesterol, assist in defecation, and suppress postprandial increase in blood glucose. Such dietary fibers include guar gum, glucomannan, oats, indigestible maltodextrins, soybean, barley, corn bran, inulin, cardiotonic, and polydextrose. In particular, maltodextrin is effective for reducing blood sugar and lowering the cholesterol level, and has high acidity and heat stability, which makes it easy to produce food.
차전자피는 차전자의 껍질을 분쇄하여 식용에 적합하도록 만든 것으로 70% 이상의 식이섬유를 함유하고 있고, 콜레스테롤 개선과 배변활동을 원활하게 하는 기능을 한다. 이러한 차전자피의 생리적 효과는 인체의 효소에 의해 분해되지 않으므로 장내 당의 흡수를 지연시켜 당뇨병 및 비만 환자에 도움을 주고, 장관 점막에 영양을 공급하며, 변의 무게 및 수분의 함량을 증가시켜 배변에 도움을 준다.
It contains more than 70% of dietary fiber, which improves cholesterol and improves bowel activity. The physiological effect of this cardiomyopathy is not decomposed by the enzymes of the human body, thereby delaying the absorption of intestinal glucose, thereby helping diabetes and obesity patients, supplying nutrition to the intestinal mucosa, increasing the weight and moisture content of the stomach, give.
폴리덱스트로스는 수용성의 난소화성 다당류로서 열량이 1㎉/g로서 낮으며, 혈중 콜레스테롤 수치를 낮추고 발암물질을 체외로 배출하여 당뇨병, 고지혈증, 대장암 등 성인병을 예방할 수 있는 효과가 있을 뿐만 아니라 대변의 용적을 증가시키고 산도(pH)를 낮게 유지시켜 준다.
Polydextrose is a water-soluble, indigestible polysaccharide whose calories are as low as 1 ㎉ / g. It lowers blood cholesterol levels and excretes carcinogens out of the body to prevent adult diseases such as diabetes, hyperlipemia and colon cancer, And maintains the pH at a low level.
프락토올리고당은 건강기능식품의 기능성 원료로서, 극히 소량만이 위산에 의해 분해되지 않고 대장에서 장내 세균에 의해 발효되고, 발효로 생성된 단쇄지방산은 장내 환경을 산성화하여 장내 세균의 에너지원으로 작용한다. 또한 프록토올리고당은 배변활동을 원활하게 함과 아울러 칼슘의 흡수에 도움을 준다.
Fructooligosaccharide is a functional raw material for health functional foods. Only a small amount of fructooligosaccharide is fermented by intestinal bacteria in the large intestine without being degraded by gastric acid. The short-chain fatty acid produced by fermentation acidifies the intestinal environment and acts as an energy source of intestinal bacteria do. In addition, fructooligosaccharides facilitate the absorption of calcium as well as facilitating bowel movements.
비타민C는 백색을 띤 결정 또는 결정성 가루로 냄새가 없고 신맛을 가지고 있으며 열에 의해 쉽게 파괴된다. 비타민C는 항산화 물질로 암, 동맥경화, 류머티즘 등을 예방해 주며, 혈관이완과 혈소판 응집 억제 역할을 하는 프로스타글란딘 생성을 증가시키고, 또한 LDL 콜레스테롤을 감소시킨다. 또한 피부 건강에 도움을 주고 노화를 방지한다. 특히 최근 연구결과에 의하면 비타민C는 식욕 억제 및 체중 감량의 효과가 있으며, 식이섬유와 함께 섭취하면 그 효과가 더 크다.
Vitamin C is a white crystalline or crystalline powder that has no smell, is sour and is easily destroyed by heat. Vitamin C is an antioxidant that prevents cancer, atherosclerosis, rheumatism, and increases prostaglandin production, which also plays a role in blood vessel relaxation and platelet aggregation inhibition, and also reduces LDL cholesterol. It also helps skin health and prevents aging. In particular, recent studies have shown that vitamin C is effective in suppressing appetite and weight loss, and is more effective when taken with dietary fiber.
과라나추출물 분말은 신진대사활동을 높이는 기능을 하는 것으로서, 강장 효과, 운동능력 향상 효과 및 지방분해 효과를 갖는데, 이는 그 안에 함유된 카페인, 테오브로민 및 탄닌이 갖는 특성에 의해 제공된다. 이는 신경계 자극제, 특히 교감신경부신계 자극제처럼 행동하며, 기초 대사의 증가, 지방 산화 및 각성을 초래한다.(Boozer CN, Nasser JA, Heymsfield SB, etal. An herbal supplement containing ma huang-guarana for weight loss: a randomized, double-blindtrial. Int J Obes Relat Metab Disord, 2001, 25:316-324)
Guarana extract powder has the function of enhancing metabolism activity, and has a tonic effect, an athletic performance improving effect and a fat dissolving effect, which are provided by the properties of caffeine, theobromine and tannin contained therein. It acts like a neurotoxic stimulant, especially a sympathetic neurogenic stimulant, resulting in increased basal metabolism, fat oxidation and arousal (Boozer CN, Nasser JA, Heymsfield SB, et al.) An herbal supplement containing ma huang-guarana for weight loss : a randomized, double-blindtrial. Int J Obes Relat Metab Disord, 2001, 25: 316-324)
마테추출물 분말은 체지방 분해 외에 식욕을 억제하는 기능을 하는 것으로서, 차와 유사한 항산화 폴리페놀을 함유한다. 마테는 지방 대사를 증가시킬 수 있으므로 체중 감량제로서 유용하다.(Martinet A, Hostettmann K, Schutz Y, etal.Thermogenic effects of commercially available plantpreparations aimed at treating human obesity. Phytomedicine, 2000, 6:231-8)
Mate extract powder, which functions to inhibit appetite in addition to body fat breakdown, contains tea-like antioxidant polyphenols. Mate is useful as a weight loss agent because it can increase fat metabolism (Martinet A, Hostettmann K, Schutz Y, et al. Pharmacotherapeutics, 2000, 6: 231-8)
이하에서는 본 발명에 따른 바(Bar) 형상의 다이어트용 기능성 식품 제조방법에 대해 상술한다.
Hereinafter, a bar-shaped method for producing a functional food for diet according to the present invention will be described in detail.
본 발명에 따른 바(Bar) 형상의 다이어트용 기능성 식품 제조방법에 있어서는 물엿을 사용하지 않고, 프락토올리고당을 사용한다.
In the bar-shaped functional food production method for diet according to the present invention, fructo-oligosaccharides are used without using starch syrup.
먼저 액상의 프락토올리고당 20.0~25.0중량%와 블루베리 농축액 2.5~3.5중량%를 포함하는 혼합액을 100℃의 온도로 가열하면서 교반한다.
First, a mixed solution containing 20.0 to 25.0% by weight of fructooligosaccharide in a liquid phase and 2.5 to 3.5% by weight of a blueberry concentrate is stirred while being heated to a temperature of 100 ° C.
상기 혼합액에 분말 성분을 투입하여 혼합한다. 여기서 투입되는 분말 성분은 차전자피 분말 1.0~3.0중량%, L-카르니틴 분말 2.0~2.5중량%, 폴리덱스트로스 분말 1.6~2.4중량%, 녹차추추물 분말 0.2~0.4중량% 및 가르시니아 캄보지아 분말 1.5~2.5중량% 등이다. 또한 분말 성분을 투입하여 혼합할 때 용이하게 혼합작용이 이루어질 수 있도록 혼합액의 온도를 80℃로 함이 적당하다.Powder components are added to the mixed solution and mixed. Carnitine powder of 2.0 ~ 2.5 wt%, polydextrose powder of 1.6 ~ 2.4 wt%, green tea extract powder of 0.2 ~ 0.4 wt% and Garcinia cambogia powder of 1.5 ~ 2.5 wt% . In addition, it is appropriate to set the temperature of the mixed solution to 80 캜 so that the mixing action can be easily performed when the powder components are mixed and mixed.
한편, 상기와 같은 분말 성분의 혼합단계에서 마테추출물 분말 0.5~0.7중량% 및 과라나추출물 분말 0.5~0.7중량%를 더 첨가하여 카페인 성분에 의한 식욕억제 기능을 강화하고, 지방분해를 더욱 촉진할 수 있다.Meanwhile, in the mixing step of the powder ingredients, 0.5 to 0.7 wt% of the matte extract powder and 0.5 to 0.7 wt% of the guarana extract powder are further added to enhance the appetite suppression function by the caffeine ingredient, have.
또한, 위와 같은 분말 성분의 혼합단계에서 대두 분말을 첨가할 수도 있는데, 대두는 고단백질 식품으로 대두에 포함된 단백질은 글루텐 성분을 포함하여 점착력이 있으며, 프로테오스 성분도 포함하고 있다. 특히 대두는 녹말을 거의 함유하지 않으므로 다이어트용 기능성 식품의 원료로 매우 적합하다.
In addition, soybean powder may be added in the mixing step of the above powder components. Soybean is a high-protein food. Protein contained in soybean is adhesive, including gluten component, and also includes protein component. In particular, soybeans contain little starch, making them very suitable as a raw material for dietary functional foods.
상기와 같은 분말 혼합액에 고형 성분을 투입하여 혼합한다. 여기서 고형 성분은 견과류 20.0~25.0중량%, 건조과일 7.0~11.0중량% 및 볶음들깨 4.0~5.0중량% 등이다. 여기서 고형 성분을 투입 및 혼합할 때의 혼합액의 온도는 40~45℃가 되도록 함이 바람직한데, 이는 비타민, 무기질 등 기능성 성분의 손실을 최소화하기 위한 것이다.A solid component is added to and mixed with the powder mixture solution as described above. Here, the solid component is 20.0 ~ 25.0% by weight of nuts, 7.0 ~ 11.0% by weight of dried fruits and 4.0 ~ 5.0% by weight of roasted sesame seeds. Here, it is preferable that the temperature of the mixed liquid at the time of introducing and mixing the solid component is 40 to 45 캜, in order to minimize loss of functional ingredients such as vitamins and minerals.
또한, 견과류와 건조과일 등과 같은 고형 성분을 분말 성분보다 나중에 투입하는 것은 혼합시 교반으로 인한 견과류와 건조과일의 분쇄를 최소화하여, 씹힘 효과에 의한 GLP-1(글루카곤 유사 펩타이드-1) 호르몬의 분비를 더욱 촉진시키기 위한 것이다.In addition, the introduction of a solid component such as nuts and dried fruits later than the powder component minimizes the grinding of nuts and dried fruits due to agitation during mixing, and the secretion of GLP-1 (glucagon-like peptide-1) .
여기서, 볶음현미 분말을 더 첨가할 수도 있는데, 현미는 정백으로 인한 영양분의 손실이 없고 단백과 식이섬유가 풍부하다. 또한 쌀시리얼을 첨가할 수도 있다.Here, it is possible to add more roasted brown rice powder, but brown rice has no loss of nutrients due to the whitening and is rich in protein and dietary fiber. You can also add rice cereal.
또한, 견과류와 건조과일 등 고형 성분은 본 발명에 따라 제조된 바(Bar) 형상의 다이어트용 기능성 식품을 섭취할 때 씹는 효과를 줌으로써 다이어트로 인한 스트레스 해소와 미감을 증대시킬 뿐만 아니라 GLP-1(글루카곤 유사 펩타이드-1) 호르몬의 분비를 더욱 촉진시키는 기능을 한다. 특히 건조과일은 섭취 후 체내에서 수분을 흡수하여 팽창하므로 포만감을 증대시키는 기능을 한다.In addition, solid ingredients such as nuts and dried fruits are effective in chewing the bar-shaped dietary functional food prepared according to the present invention, thereby increasing stress relief and aesthetics caused by dieting, as well as enhancing GLP-1 Glucagon-like peptide-1) hormone secretion. In particular, dry fruit absorbs moisture in the body after ingestion and swells so that it functions to increase satiety.
한편, 상기 견과류는 해바라기씨, 호박씨, 아몬드, 캐슈넛, 호두, 잣 또는 은행 중에서 어느 하나 이상이 선택되어 지는 것을 특징으로 한다. 이와 같은 견과류에는 불포화지방산이 풍부할 뿐만 아니라 비타민E, 철분, 칼슘 성분이 많이 포함되어 있고, 혈액의 콜레스테롤 함량을 감소시킨다.On the other hand, the nuts are characterized in that at least one of sunflower seed, pumpkin seed, almond, cashew nut, walnut, pine nut or bank is selected. These nuts are not only rich in unsaturated fatty acids, but also contain a large amount of vitamin E, iron and calcium, reducing the cholesterol content of the blood.
또한, 상기 건조과일은 크랜베리, 블루베리, 포도, 라즈베리 또는 체리 중 어느 하나 이상이 선택되어 지는 것을 특징으로 한다. 특히 크랜베리는 박테리아가 체내에 부착하는 것을 방지하는 효과가 있으며, 크랜베리와 블루베리에 포함된 안토시아닌 색소는 시력 개선과 간기능 개선의 효과가 있다. 그리고 라즈베리에는 비타민과 미네랄이 풍부하고, 체리에는 비타민A와 칼슘 및 인과 같은 무기염류가 함유되어 있다.
In addition, the dried fruit is characterized in that at least one of cranberry, blueberry, grape, raspberry or cherry is selected. In particular, cranberry has an effect of preventing bacteria from adhering to the body, and anthocyanin pigments contained in cranberry and blueberry have the effect of improving eyesight and improving liver function. And raspberries are rich in vitamins and minerals, and cherries contain vitamin A, minerals such as calcium and phosphorus.
상기와 같은 분말 및 고형 성분 혼합액을 바(Bar) 형상으로 압축 성형한 후 제품에 적당한 크기로 절단한다.
The mixture of powder and solid component as described above is compression-molded into a bar shape, and then cut into an appropriate size for the product.
상기와 같이 제조된 바(Bar) 형상의 다이어트용 기능성 식품을 40~45℃의 열풍으로 1~3분간 건조시킨 후 상온에서 냉각한다.The bar-shaped functional food for dieting prepared as described above is dried for 1 to 3 minutes with hot air at 40 to 45 캜 and then cooled at room temperature.
여기서 건조 온도와 시간이 높으면 기능성 식품에 포함된 수분이 과증발하여 섭취시 미감이 저하되므로, 상기와 같이 제조된 바(Bar) 형상의 다이어트용 기능성 식품이 적정한 수분량을 함유할 수 있도록 함과 아울러 건조 후 비타민C의 도포가 용이하게 이루어질 수 있도록 건조온도와 건조시간을 위와 같이 조절할 필요가 있다.
Herein, when the drying temperature and time are high, the moisture contained in the functional food is evaporated and the sensation is reduced during ingestion. Therefore, the bar functional food for dieting as described above can contain an appropriate amount of water, It is necessary to adjust the drying temperature and the drying time as described above so that the application of vitamin C can be easily performed after drying.
한편, 비타민C와 같은 영양소는 열에 약하므로 위와 같이 제조된 다이어트용 기능성 식품의 표면에 비타민C 분말을 도포하여 제조과정에서 파괴된 영양소를 보충한다. 즉, 비타민C 분말 80~150mg을 액상의 프락토올리고당 또는 벌꿀과 부피대비 1:1의 비율로 혼합하여 그 혼합물을 상기와 같이 제조된 다이어트용 기능성 식품의 표면에 도포할 수도 있다.
On the other hand, since nutrients such as vitamin C are weak to heat, vitamin C powder is applied to the surface of functional foods for dieting, which are prepared as described above, to supplement nutrients that have been destroyed during the manufacturing process. That is, 80 to 150 mg of vitamin C powder may be mixed with the liquid fructooligosaccharide or honey at a ratio of 1: 1 by volume, and the mixture may be applied to the surface of the functional food for diet produced as described above.
이하는 본 발명에 따라 제조된 바(Bar) 형상의 다이어트용 기능성 식품을 섭취한 실험자들을 대상으로 체중 감소량 및 체지방 감소량 등의 실험을 한 결과이다. 실험 참가자 집단은 남성 13명과 여성 37명으로 총 50명으로 구성되었으며, 참가자 연령은 20대가 7명, 30대가 10명, 40대가 13명, 50대가 15명, 60대 이상이 5명이다.
Hereinafter, the results of experiments on weight loss and amount of body fat reduction in experimental subjects taking a bar-shaped dietary functional food prepared according to the present invention. The experimental participants consisted of 13 men and 37 women. The age of participants was 7 in the 20s, 10 in the 30s, 13 in the 40s, 15 in the 50s, and 5 in the 60s.
실험예Experimental Example
1 One
이들 50명의 실험 참가자들을 대상으로 본 발명에 따른 바 형상의 다이어트용 기능성 식품을 30일간 1일 3회(1회당 30g) 섭취하게 한 후 체중, 체지방량 및 근육량의 변화치를 평균화한 값은 아래 표 1과 같다.
The values obtained by averaging the changes in body weight, body fat mass, and muscle mass after the bar-shaped functional food for diet according to the present invention were taken three times a day for 30 days (30 g per one time) Respectively.
위 표 1에 나타난 바와 같이 실험 참가자 집단의 평균 체중은 3.2kg 감소하였고, 체지방량은 2.6kg 감소한데 반해 근육량의 감소는 0.4kg에 불과하였다.
As shown in Table 1 above, the average body weight of the participant group was reduced by 3.2 kg, while the body fat mass was reduced by 2.6 kg, while the muscle mass decreased by only 0.4 kg.
실험예Experimental Example
2 2
실험 참가자들에게 본 발명에 따른 바 형상의 다이어트용 기능성 식품의 섭취시 미감, 씹힘성에 의한 스트레스 해소 여부, 식욕억제효과, 섭취 후 30분 경과한 시점에서의 포만감에 관하여 조사한 결과는 아래 표 2와 같다.
The results of the study were as follows. Table 2 shows the results of the experiment. The results were as follows. Table 2 < tb >< TABLE > Id = Table 2 Columns = 5 < tb > same.
매우 나쁨 1점, 나쁨 2점, 보통 3점, 좋음 4점, 매우 좋음 5점Very bad 1 point, poor 2 points, average 3 points, good 4 points, very good 5 points
(소수점 2자리 이하는 버림)
(Decimals less than two decimal places)
특히 실험 참가자들은 본 발명에 따라 제조된 바(Bar) 형상의 다이어트용 기능성 식품에 포함된 견과류 및 건조과일을 씹을 때 쉽게 포만감을 느낄 수 있었고, 다이어트로 인한 스트레스 해소에도 많은 도움이 된다고 응답하였다.
Particularly, the participants of the experiment replied that they could easily feel a fullness feeling when chewing nuts and dried fruits contained in the bar-shaped functional food for diets manufactured according to the present invention and also helped relieve the stress due to the diet.
위와 같은 실험을 통해 본 발명에 따라 제조된 바(Bar) 형상의 다이어트용 기능성 식품이 체중 감량을 하고자 하는 사람들에게 좋은 반응을 얻을 수 있음을 알 수 있다.
It can be seen from the above experiment that a bar-shaped functional food for dieting manufactured according to the present invention can provide a good response to people who want to lose weight.
상기한 바와 같은 실시태양은 일 실시예에 불과함은 당연하다 할 것이며, 따라서 본 발명의 권리범위는 이에 제한해석되어서는 아니 될 것이다.It is to be understood that the above-described embodiments are only examples, and thus the scope of the present invention should not be construed as being limited thereto.
Claims (4)
80℃의 온도에서 상기 혼합액에 차전자피 분말 1.0~3.0중량%, L-카르니틴 분말 2.0~2.5중량%, 폴리덱스트로스 분말 1.6~2.4중량%, 녹차추추물 분말 0.2~0.4중량% 및 가르시니아 캄보지아 분말 1.5~2.5중량%를 투입하여 혼합하는 단계;
40~45℃의 온도에서 상기 분말 혼합액에 고형의 견과류 20.0~25.0중량%, 건조과일 7.0~11.0중량% 및 볶음들깨 4.0~5.0중량%를 투입하여 혼합하는 단계;
상기 분말 및 고형 성분의 혼합액을 바 형상으로 압축 성형 및 절단하는 단계; 및
40~45℃의 열풍으로 1~3분간 건조시킨 후 상온에서 냉각하는 단계;
로 이루어진 것을 특징으로 하는 바 형상의 다이어트용 기능성 식품 제조방법.
Stirring a mixture solution containing 20.0 to 25.0% by weight of fructooligosaccharides in a liquid phase and 2.5 to 3.5% by weight of a blueberry concentrate with heating at a temperature of 100 ° C;
Carnitine powder, 2.0 to 2.5% by weight of polydextrose powder, 1.6 to 2.4% by weight of polydextrose powder, 0.2 to 0.4% by weight of green tea extract powder and 1.5 to 2.5% by weight of carnauba wax powder, % By weight;
Adding 20.0 ~ 25.0% by weight of solid nuts, 7.0 ~ 11.0% by weight of dried fruits and 4.0 ~ 5.0% by weight of roasted sesame seeds to the powder mixture at a temperature of 40 to 45 ° C;
Compressing and cutting the mixed liquid of the powder and the solid component into a bar shape; And
Drying for 1 to 3 minutes with hot air at 40 to 45 캜 and cooling at room temperature;
≪ RTI ID = 0.0 > 1. ≪ / RTI >
The method according to claim 1, wherein 80 to 150 mg of vitamin C powder is mixed with liquid fructooligosaccharide or honey in a ratio of 1: 1 to volume, and the mixture is applied to the surface of the cooled bar shaped functional food for diet Wherein the bar is shaped like a bar.
The method according to claim 1, wherein the nuts are selected from at least one of sunflower seeds, pumpkin seeds, almonds, cashews, walnuts, pine nuts, or banknuts, and the dry fruit is at least one of cranberry, blueberry, grape, raspberry, Is selected as the active ingredient.
[2] The method according to claim 1, wherein 0.5 to 0.7% by weight of a matte extract powder and 0.5 to 0.7% by weight of a guarana extract powder are further added to the powder component.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140045175A KR101456415B1 (en) | 2014-04-16 | 2014-04-16 | The method of manufacturing bar-shaped functional food for diet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140045175A KR101456415B1 (en) | 2014-04-16 | 2014-04-16 | The method of manufacturing bar-shaped functional food for diet |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101456415B1 true KR101456415B1 (en) | 2014-10-31 |
Family
ID=51999005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140045175A KR101456415B1 (en) | 2014-04-16 | 2014-04-16 | The method of manufacturing bar-shaped functional food for diet |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101456415B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160126474A (en) * | 2015-04-23 | 2016-11-02 | 예진비앤지 주식회사 | Diet nuts manufacturing method |
KR101806462B1 (en) | 2016-10-17 | 2017-12-07 | 주식회사 하슬라에프엔비 | Method for Manufacturing Anthocyanin Energy Bar |
KR101896024B1 (en) | 2017-06-14 | 2018-09-06 | 주식회사 슈퍼내츄럴스 | Functional food compositions comprising extracts of Garcinia Cambogia as active ingredients and method for preparing the same |
CN109730270A (en) * | 2019-02-12 | 2019-05-10 | 西安培华学院 | A kind of hypoglycemic yeast fermentation pumpkin powder and preparation method and application |
KR20210000870A (en) | 2019-06-26 | 2021-01-07 | 김의현 | Method of functional food using bean-curd residue and whey protein isolate |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0180453B1 (en) * | 1996-10-08 | 1999-10-01 | 주식회사태평양 | Composition for diet |
KR20050039286A (en) * | 2003-10-24 | 2005-04-29 | 김원규 | Cookie comprising eatable fiber and prepararing method thereof |
KR100856241B1 (en) * | 2007-04-25 | 2008-09-03 | 웅진식품주식회사 | A diet food composition using an agar |
-
2014
- 2014-04-16 KR KR1020140045175A patent/KR101456415B1/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0180453B1 (en) * | 1996-10-08 | 1999-10-01 | 주식회사태평양 | Composition for diet |
KR20050039286A (en) * | 2003-10-24 | 2005-04-29 | 김원규 | Cookie comprising eatable fiber and prepararing method thereof |
KR100856241B1 (en) * | 2007-04-25 | 2008-09-03 | 웅진식품주식회사 | A diet food composition using an agar |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160126474A (en) * | 2015-04-23 | 2016-11-02 | 예진비앤지 주식회사 | Diet nuts manufacturing method |
KR101717427B1 (en) | 2015-04-23 | 2017-03-27 | 예진비앤지 주식회사 | Nuts manufacturing method |
KR101806462B1 (en) | 2016-10-17 | 2017-12-07 | 주식회사 하슬라에프엔비 | Method for Manufacturing Anthocyanin Energy Bar |
KR101896024B1 (en) | 2017-06-14 | 2018-09-06 | 주식회사 슈퍼내츄럴스 | Functional food compositions comprising extracts of Garcinia Cambogia as active ingredients and method for preparing the same |
CN109730270A (en) * | 2019-02-12 | 2019-05-10 | 西安培华学院 | A kind of hypoglycemic yeast fermentation pumpkin powder and preparation method and application |
KR20210000870A (en) | 2019-06-26 | 2021-01-07 | 김의현 | Method of functional food using bean-curd residue and whey protein isolate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100856241B1 (en) | A diet food composition using an agar | |
CN104872504A (en) | Meal-replacing powder capable of replacing daily diet and having balanced nutrition and preparation method of meal-replacing powder | |
US20220030909A1 (en) | Intact Pea Protein-Based Nutrient Composition | |
CN104287049A (en) | Meal replacement protein powder solid beverage for managing body weight | |
JP2007535576A (en) | Nutritional composition that promotes rapid weight loss, burns calories, increases heat generation, assists in energy metabolism and / or suppresses appetite | |
KR101456415B1 (en) | The method of manufacturing bar-shaped functional food for diet | |
WO2022016774A1 (en) | Composition beneficial for regulating intestinal tract, promoting digestion and improving constipation, and preparation method therefor | |
CN108719984B (en) | Meal replacement nutrition bar for gout population and preparation method thereof | |
CN108782874A (en) | A kind of selenium-rich black tea drinks | |
CN105031042A (en) | Medicinal composition having weight-loss function and application of medicinal composition | |
KR101896024B1 (en) | Functional food compositions comprising extracts of Garcinia Cambogia as active ingredients and method for preparing the same | |
CN111280280A (en) | Low-sugar weight-reducing coffee and preparation method thereof | |
KR100549089B1 (en) | A Health Care Composition for treating or preventing intestinal disease and constipation | |
KR102422527B1 (en) | Supplement food composition for diet | |
KR20200043555A (en) | Supplement food composition for diet | |
CN103549083A (en) | Health-protection and lift-nourishing tea | |
CN104255883A (en) | Health protection cake capable of adjusting blood glucose and blood fat and production method thereof | |
JP2008050301A (en) | Pancreatic lipase inhibitor | |
KR101344564B1 (en) | Composition comprising extract of hot peppers and Chinese peppers for preventing or treating of obesity or hyperlipidemia | |
KR100488512B1 (en) | healthy foodstuffs mainly including seed oil of evening primrose and the composion thereof | |
RU2579215C1 (en) | Dry mixture for beverage preparation | |
US20240000091A1 (en) | Nutritional supplement for lactating mothers | |
KR101874842B1 (en) | Lotus Root of PreparationMethod Thereof | |
KR101688392B1 (en) | Method for producing diet food for reducing body fat | |
CN112120151A (en) | Quinoa rice flour production formula |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |